Placental vascular maldevelopment,intrauterine growth restriction,and pulmonary hypertension

Case description

A 33-year-old gravida 2, para 1 woman was referred to obstetrical triage at 28 weeks, 0 days gestation for severe intrauterine growth restriction (IUGR) with absent end-diastolic flow on umbilical arterial Doppler ultrasound. Estimated fetal weight was <400 g. Maternal serologies were all negative. Group B streptococcal status was unknown. Membranes were ruptured at delivery. First trimester screening for aneuploidy was risk-reducing. TORCH workup was not pursued as IUGR was attributed to severe pre-eclampsia. In obstetrical triage, blood pressure was 184/104. She received labetalol and one dose of betamethasone four hours prior to delivery. She underwent cesarean section and delivered a live-born male infant at 28 weeks weighing 460 g (birth weight-for-gestational age <<1st percentile). Apgar scores were 5 and 8 at 1 and 5 min, respectively. The infant was vigorous but with poor air movement bilaterally and was provided positive pressure ventilation by bag-mask ventilation. He began breathing spontaneously with decreased respiratory distress and was transferred to the NICU on non-invasive continuous positive airway pressure (CPAP). Initial chest x-ray demonstrated clear lungs with minimal hyaline membrane disease. No surfactant was given because he was not intubated.

He remained on nasal CPAP (PEEP: 6, FiO₂ < 0.3) until day of life (DOL) 35, when he was noted to have increased work of breathing and oxygen requirement. X-ray demonstrated increased perihilar/interstitial opacities and mild hypoinflation. Respiratory support was changed to (non-invasive) nasal intermittent positive pressure ventilation (NIPPV; PIP: 24, PEEP: 7, rate: 40). Blood and urine cultures were collected and broad spectrum antibiotics started. His first echocardiogram was performed and was notable for mild biventricular hypertrophy and patent foramen ovale (PFO) with left to right flow and no evidence of elevated pulmonary pressures or patent ductus arteriosus. He achieved full feeds by DOL 19. His weight, though below the first percentile (Z-score –3.5), tracked consistently with his postmenstrual age. He remained stable on NIPPV until DOL 49, when he was transitioned back to nasal CPAP (PEEP 7).

At DOL 57, he had increasing work of breathing and was transitioned back to NIPPV. Sepsis/infection was ruled out. Repeat echocardiogram revealed right ventricle dilation and hypertrophy, bidirectional shunting across the PFO, flattened interventricular septum, and mild tricuspid valve regurgitation with peak gradient 66 mmHg. The patient was intubated for the first time ever and placed on conventional ventilation (5 mL/kg tidal volume, Pmax: 24, PEEP: 7, rate: 40). X-ray demonstrated increased bilateral interstitial opacities.

At DOL 61, he passed a bloody stool and abdominal x-ray revealed pneumatosis consistent with medical necrotizing enterocolitis (NEC). Bowel rest and broad-spectrum antibiotics were started. He continued to require escalating ventilator support (PEEP: 8, PIP: 26, FiO₂: 0.6). Repeat echocardiogram at DOL 64 demonstrated bowing of the interventricular septum into the left ventricle and continuous right-to-left flow across the PFO, consistent with worsening pulmonary hypertension (PH). Inhaled nitric oxide was initiated at 20 ppm. Over the following three days, he required increased FiO₂ to 1.0. On DOL 67, he was muscle-relaxed and transitioned to high frequency ventilation (mean airway pressure ∼16 cm H₂O). Repeat echo revealed worsening RV hypertrophy, dilation, and bowing into the LV. With ongoing consultation by the PH team, milrinone, sildenafil, norepinephrine, and inhaled treprostinil were added and titrated over the following 24–48 h. Despite these measures, the patient’s gas exchange and oxygenation continued to decline, and at DOL 74, he developed bradycardia with poor perfusion and died despite resuscitative efforts. His parents provided written consent for autopsy and publication of this case.

The placenta was submitted to pathology for routine gross and histologic evaluation within 24 h after birth. Placental weight was small-for-gestational age (108 g, expected placental weight 210–331 g). Three-vessel umbilical cord was noted. Histology revealed evidence of maternal vascular malperfusion (MVM), specifically mural hypertrophy of membrane arterioles (Fig. 1g), persistent muscularization of basal plate arteries (Fig. 1h), and accelerated villous maturation with sparse, poorly vascularized villi (Fig. 1b). ¹ OPEN IN VIEWER

Lungs at autopsy were noted to have thickened alveolar septae, alveolar simplification, and hyaline membrane formation. Findings of established, advanced pulmonary vascular disease were present and included intimal fibroplasia of arterial branches (Fig. 1c and i) and thickened muscular arterioles in interalveolar spaces. Cardiac examination was notable for biventricular hypertrophy, with right ventricular wall thickness of 0.6 cm (normal estimated 0.3 cm for age) and left ventricular wall thickness of 0.7 cm (normal estimated 0.42 cm for age).

Additional immunofluorescent staining of the placenta and lungs was performed with von Willebrand factor (vWF) to explore relative vessel density and disruption of vascular endothelium (Fig. 1d–f). Staining of the chorionic villi qualitatively showed increased vascular density in a control placenta (Fig. 1d) as compared to the case (Fig. 1e), while increased intensity of the signal in the case placenta demonstrated endothelial disruption consistent with previous reports of pre-eclamptic placentas. ² Infant lung tissue from a healthy control was not available; however, vWF immunofluorescence of the case infant’s lungs shows dramatic endothelial disruption in pulmonary arterioles (Fig. 1f). Qualitatively, there were sparse small arterioles identified by vWF staining (not shown).

Discussion

This is the case of a pregnancy complicated by maternal pre-eclampsia, severe IUGR, and neonatal course complicated by bronchopulmonary dysplasia (BPD), a second-hit (inflammatory) insult of NEC, and subsequent severe, refractory PH at 36 weeks postmenstrual age. Placental pathology had features of MVM, including placental growth restriction, decidual vessel pathology, and villous changes. Autopsy revealed hypertrophied and muscularized pulmonary arterioles with intimal fibroplasia consistent with advanced PH disease.

BPD-associated PH is a serious complication of prematurity, and PH incurs a four-fold increased risk of mortality over BPD alone. Postnatal factors such as inflammation, oxygen exposure, and mechanical ventilation contribute to ongoing pulmonary alveolar and vascular maldevelopment after birth. ³ Before birth, the intrauterine environment may also play a role in the development of BPD and PH.

Direct associations between IUGR, BPD, and PH have been reported.^4,5 IUGR is a complex process with numerous etiopathologies, and placental insufficiency is a well-described cause. ⁶ Comparison of placental pathology and lung disease has shown that severe MVM and distinct sublesions of MVM, as well as decreased villous vascularity are associated with BPD-PH.^7–9 In ovine models, lungs of growth-restricted fetuses have alveolar simplification and decreased vascular density similar to human BPD. In IUGR sheep, pulmonary artery endothelial cells demonstrate decreased proliferative capacity in response to growth factors. ¹⁰ Nuclear factor-κB expression, important in fetal pulmonary angiogenesis, is reduced in pulmonary artery endothelial cells isolated from IUGR fetal sheep. ¹¹

This case illustrates mirror images in placental and pulmonary histopathology that support common mechanisms of vascular development, and possible links between placental and pulmonary vascular growth. The role of the placenta as an early predictor of neonatal PH is supported. Research on the fetal programming of cardiopulmonary disease is ongoing.